1. FRI0161 A Phase 1B/2A Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of XMAB®5871 in Patients with Rheumatoid Arthritis. (9th June 2015) Authors: Jaraczewska-Baumann, M.; Korkosz, M.; Sulyok, G.; Sramek, P.; Rojkovich, B.; Daniluk, S.; Bartalos, J.; Zack, D.J.; Foster, P. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 481 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗